Solubility and stability of taxol: Effects of buffers and cyclodextrins

被引:116
作者
Dordunoo, SK
Burt, HM
机构
[1] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,VANCOUVER,BC V6T 1Z3,CANADA
[2] ANGIOGENESIS TECHNOL INC,VANCOUVER,BC V6E 3X1,CANADA
关键词
taxol; solubility; pH-stability; cyclodextrins complexation;
D O I
10.1016/0378-5173(96)04443-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The degradation kinetics of taxol in aqueous solutions were investigated at 37 degrees C over a pH range of 1-9. The hydrolysis rates followed pseudo first-order kinetics with respect to residual taxol concentration. The pH-rate profile at 37 degrees C showed that a maximum stability of taxol occurred in the pH 3-5 region. The effect of gamma-cyclodextrin (gamma CD), hydroxypropyl-gamma-cyclodextrin (HP gamma CD) and hydroxypropyl-beta-cyclodextrin (HP beta CD) on the solubility and stability of taxol was also investigated. Taxol was more stable in cyclodextrin solution than in buffer solution of comparable pH. The solubility of taxol in water increased in the presence of cyclodextrins with HP beta CD giving the greatest increase in taxol solubility. Taxol (as received) was anhydrous and on suspension in water, it dissolved to form a supersaturated solution which recrystallized as a hydrate of lower solubility. Taxol formed predominantly second order complexes with the cyclodextrins. Complexes of taxol with HP beta CD were more stable than those of HP gamma CD or gamma CD. Further increase in the solubility of taxol was observed when ethanol was added as a co-solvent.
引用
收藏
页码:191 / 201
页数:11
相关论文
共 27 条
[1]  
[Anonymous], PHARM TECHNOL INT
[2]   INVITRO AND INVIVO ANTITUMORAL ACTIVITY OF FREE, AND ENCAPSULATED TAXOL [J].
BARTOLI, MH ;
BOITARD, M ;
FESSI, H ;
BERIEL, H ;
DEVISSAGUET, JP ;
PICOT, F ;
PUISIEUX, F .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (02) :191-197
[3]   CONTROLLED DELIVERY OF TAXOL FROM MICROSPHERES COMPOSED OF A BLEND OF ETHYLENE-VINYL ACETATE COPOLYMER AND POLY (D,L-LACTIC ACID) [J].
BURT, HM ;
JACKSON, JK ;
BAINS, SK ;
LIGGINS, RT ;
OKTABA, AMC ;
ARSENAULT, AL ;
HUNTER, WL .
CANCER LETTERS, 1995, 88 (01) :73-79
[4]  
CSERHATI T, 1994, INT J PHARM, V108, P64
[5]   TAXOL ENCAPSULATION IN POLY(EPSILON-CAPROLACTONE) MICROSPHERES [J].
DORDUNOO, SK ;
JACKSON, JK ;
ARSENAULT, LA ;
OKTABA, AMC ;
HUNTER, WL ;
BURT, HM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (04) :279-282
[6]   A NONSURFACTANT FORMULATION FOR ALFAXALONE BASED ON AN AMORPHOUS CYCLODEXTRIN - ACTIVITY STUDIES IN RATS AND DOGS [J].
ESTES, KS ;
BREWSTER, ME ;
WEBB, AI ;
BODOR, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 65 (1-2) :101-107
[7]  
Higuchi T., 1965, Interscience, New York, V4, P117
[8]   NEW TAXANES FROM TAXUS-BREVIFOLIA .2. [J].
HUANG, CHO ;
KINGSTON, DGI ;
MAGRI, NF ;
SAMARANAYAKE, G ;
BOETTNER, FE .
JOURNAL OF NATURAL PRODUCTS, 1986, 49 (04) :665-669
[9]   PROFILING TAXANES IN TAXUS EXTRACTS USING LC/MS AND LC/MS/MS TECHNIQUES [J].
KERNS, EH ;
VOLK, KJ ;
HILL, SE ;
LEE, MS .
JOURNAL OF NATURAL PRODUCTS, 1994, 57 (10) :1391-1403
[10]   THE CHEMISTRY OF TAXOL, A CLINICALLY USEFUL ANTICANCER AGENT [J].
KINGSTON, DGI ;
SAMARANAYAKE, G ;
IVEY, CA .
JOURNAL OF NATURAL PRODUCTS, 1990, 53 (01) :1-12